Solutions for Success
Provides innovative commercialisation strategies and market development advice to medical devices businesses
Pharma Devices provides innovative commercialisation market development advice to growing medical device businesses
Bringing a new product into the market place is an exciting but challenging time for innovators. Most new products and technologies falter along the product development journey due to missteps in strategy and execution. The risk can be lowered by engaging an expert to guide your commercialisation and market development approach. Deciding when, how and where to launch your product will determine its early impact on the market. By investing in your customised path to market you are taking the important steps to ensure its success.
With over 20 years experience in the medical device industry, Pharma Devices is a specialised consultancy that provides innovative product launching and commercialisation approaches for growing medical devices businesses operating in the Australian and Asia Pacific Regions. Our clients range from early stage start-ups through to multinational corporations working on a global level.
Our value proposition
We work closely with our clients to understand the key barriers to commercialisation for their products and technologies such as regulatory and market access, and then develop strategies based on a range of customised solutions. Solutions aimed at seamless market entry often include market research, key opinion leader engagement, reimbursement, sales planning and marketing.
We bring together professionals with significant industry experience along with extensive networks and relationships to deliver your financial success in an increasingly complex healthcare environment.
CHRIS CARTER – Director
Chris Carter has more than 20 years of executive leadership experience in the Medical Device Industry having held senior positions with major multinationals including Gyrus ACMI and Olympus in Australia and the Asia-Pacific region, where he led the sales and market development of a range of diverse medical devices.
Seeing so many new products and technologies failing to thrive in the market, Chris founded Pharma Devices so he could share his years of experience in product and market development, health economics, market strategy development and product rollout. Chris’ extensive knowledge and innovative approach has been pivotal in a number of medical device companies successfully taking their ideas and products to market, including successful launches, and identifying and engaging manufacturers and distributors.
Chris holds a Batchelor of Pharmacy from Rhodes University and an MBA from Henley Business School.
We work with companies and their products and technologies at all stages across the product lifecycle from idea, concept, minimum viable product, prototype, manufacturing and product pre and post market introduction.
Our key services include:
- Medical device commercialisation strategies and plans for early stage companies
- Medical device sales planning and marketing programs
- Market landscape reports
- Key Opinion Leader (KOL) engagement activities: education and training, peer to peer engagement and proctorship programs
- Distributor identification and engagement for the Australian and Asia Pacific region.
- Health economics-based cost effectiveness models, financial modelling and marketing tools
- Development of reimbursement and regulatory strategies
- Developed a Key Opinion Leader engagement program for a device to improve patient outcomes in minimally invasive surgery. KOL program delivered the company’s sales growth objectives.
- Created an FDA Regulatory and US market reimbursement strategy for an interstitial brachytherapy device.
- Identified and engaged a quality distributor for a novel device in metabolic surgery for the Indian market.
- Developed a health economics-based product brochure for an innovative surgical imaging system with the objective of increasing sales. The strategy included developing a workshop to teach “health economics basics” and how to use the brochure to sell the product.
- Created a dynamic model to optimise treatment capacity and cost saving for a point of care diagnostic tool for use in public day oncology units.
- Created a budget saving model for a novel laparoscopic technique to deliver chemotherapeutics as part of the treatment of advanced cancers in public and private hospitals.
- Cost saving model for a point of care diagnostic tool used in the management of ambulatory high-risk febrile neutropenia patients in a community setting.
- Produced a cost benefit analysis comparing an intragastric balloon with metabolic surgery for the NSW Dept of Health.